These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

487 related articles for article (PubMed ID: 31602293)

  • 21. Clinical aspects of the Mycobacterium abscessus complexAuthors' replyClinical aspects in patients with pulmonary infection caused by mycobacteria of the Mycobacterium abscessus complex, in the Brazilian AmazonBurden of non-tuberculous mycobacterial pulmonary disease in GermanyBritish Thoracic Society guidelines for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD).
    Joob B; Wiwanitkit V
    J Bras Pneumol; 2018; 44(5):434-435. PubMed ID: 30517343
    [No Abstract]   [Full Text] [Related]  

  • 22. Management of
    Kumar K; Daley CL; Griffith DE; Loebinger MR
    Eur Respir Rev; 2022 Mar; 31(163):. PubMed ID: 35140106
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Frequency and clinical significance of respiratory isolates of non-tuberculous mycobacteria in Riyadh, Saudi Arabia.
    Al-Harbi A; Al-Jahdali H; Al-Johani S; Baharoon S; Bin Salih S; Khan M
    Clin Respir J; 2016 Mar; 10(2):198-203. PubMed ID: 25130951
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nontuberculous Mycobacteria in Cystic Fibrosis.
    Furukawa BS; Flume PA
    Semin Respir Crit Care Med; 2018 Jun; 39(3):383-391. PubMed ID: 30071553
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical relevance and diagnosis of nontuberculous mycobacterial pulmonary disease in populations at risk.
    Feng JY; Chen WC; Chen YY; Su WJ
    J Formos Med Assoc; 2020 Jun; 119 Suppl 1():S23-S31. PubMed ID: 32482607
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification and Characteristics of Co-isolation of Multiple Nontuberculous Mycobacteria.
    Asaoka M; Hagiwara E; Etori S; Higa K; Ikeda S; Sekine A; Kitamura H; Baba T; Komatsu S; Ogura T
    Intern Med; 2021 Oct; 60(20):3213-3219. PubMed ID: 33896860
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical characteristics and treatment outcomes of pleural effusions in patients with nontuberculous mycobacterial disease.
    Park S; Jo KW; Lee SD; Kim WS; Shim TS
    Respir Med; 2017 Dec; 133():36-41. PubMed ID: 29173447
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A narrative review of nontuberculous mycobacterial pulmonary disease: microbiology, epidemiology, diagnosis, and management challenges.
    Hamed KA; Tillotson G
    Expert Rev Respir Med; 2023; 17(11):973-988. PubMed ID: 37962332
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nontuberculous mycobacterial pulmonary diseases in immunocompetent patients.
    Koh WJ; Kwon OJ; Lee KS
    Korean J Radiol; 2002; 3(3):145-57. PubMed ID: 12271159
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Microbiome Diversity in Sputum of Nontuberculous Mycobacteria Infected Women with a History of Breast Cancer.
    Philley JV; Kannan A; Olusola P; McGaha P; Singh KP; Samten B; Griffith DE; Dasgupta S
    Cell Physiol Biochem; 2019; 52(2):263-279. PubMed ID: 30816674
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Global trends of pulmonary infections with nontuberculous mycobacteria: a systematic review.
    Dahl VN; Mølhave M; Fløe A; van Ingen J; Schön T; Lillebaek T; Andersen AB; Wejse C
    Int J Infect Dis; 2022 Dec; 125():120-131. PubMed ID: 36244600
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Implication of species change of Nontuberculous Mycobacteria during or after treatment.
    Lee JS; Lee JH; Yoon SH; Kim TS; Seong MW; Han SK; Yim JJ
    BMC Pulm Med; 2017 Dec; 17(1):213. PubMed ID: 29262802
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recent advances in molecular diagnostics and understanding mechanisms of drug resistance in nontuberculous mycobacterial diseases.
    Huh HJ; Kim SY; Jhun BW; Shin SJ; Koh WJ
    Infect Genet Evol; 2019 Aug; 72():169-182. PubMed ID: 30315892
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bronchiectasis and nontuberculous mycobacterial disease.
    Griffith DE; Aksamit TR
    Clin Chest Med; 2012 Jun; 33(2):283-95. PubMed ID: 22640846
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Challenging scenarios in nontuberculous mycobacterial infection in cystic fibrosis.
    Martiniano SL; Esther CR; Haworth CS; Kasperbauer SH; Zemanick ET; Caverly LJ
    Pediatr Pulmonol; 2020 Feb; 55(2):521-525. PubMed ID: 31821718
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Summary for Clinicians: 2020 Clinical Practice Guideline Summary for the Treatment of Nontuberculous Mycobacterial Pulmonary Disease.
    Kurz SG; Zha BS; Herman DD; Holt MR; Daley CL; Ruminjo JK; Thomson CC
    Ann Am Thorac Soc; 2020 Sep; 17(9):1033-1039. PubMed ID: 32870060
    [No Abstract]   [Full Text] [Related]  

  • 37. Nontuberculous Mycobacterial Infections in Cystic Fibrosis.
    Martiniano SL; Nick JA; Daley CL
    Thorac Surg Clin; 2019 Feb; 29(1):95-108. PubMed ID: 30454926
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Global Epidemiology of Nontuberculous Mycobacterial Pulmonary Disease: A Review.
    Prevots DR; Marshall JE; Wagner D; Morimoto K
    Clin Chest Med; 2023 Dec; 44(4):675-721. PubMed ID: 37890910
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nontuberculous Mycobacterial Disease Epidemiology: You Can See the Stars and Still Not See the Light.
    Griffith DE; Marras TK
    Clin Infect Dis; 2021 Jul; 73(2):e327-e329. PubMed ID: 32756945
    [No Abstract]   [Full Text] [Related]  

  • 40. In Vitro Efficacy of Free and Nanoparticle Formulations of Gallium(III) meso-Tetraphenylporphyrine against Mycobacterium avium and Mycobacterium abscessus and Gallium Biodistribution in Mice.
    Choi SR; Britigan BE; Switzer B; Hoke T; Moran D; Narayanasamy P
    Mol Pharm; 2018 Mar; 15(3):1215-1225. PubMed ID: 29421865
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.